1887

Chapter 53 : Practices of Sequencing Quality Assurance

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Practices of Sequencing Quality Assurance, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819071/9781555819088.ch53-1.gif /docserver/preview/fulltext/10.1128/9781555819071/9781555819088.ch53-2.gif

Abstract:

While the breakthrough discovery of DNA structure was in 1953, many innovations still needed to occur before labs could generate the sequential order of nucleotides in genetic material. Results began to materialize 15 years later in 1968, when Wu and Kaiser performed “cohesive end” sequencing on phage DNA using radiolabeled nucleotides and DNA polymerase (1). This method produced reads of 10 to 20 bases, and fragments were separated by two-dimensional chromatography.

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

(A) Sanger sequencing workflow. (B) Terminator nucleotides prevent further polymerization and label each fragment with a dye corresponding to the final nucleotide identity.

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

Next-generation sequencing workflow. See text for details.

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

(A) Direct PCR. (B) Fusion PCR library preparation strategies. (C) Mate-paired reads are separated by a known intervening sequence length (dashed lines), allowing for accurate relative positional alignment. See text for details.

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Image of mixed base traces viewed in RECall software showing examples of mixed base variation in HIV Sanger assay at two codon positions: amino acids 37 (aa37) and 41 (aa41). Each panel consists of sequencing traces from the forward sequencing primer (PRT-F2) and the reverse sequencing primer (AV44). Mixed base positions are identified by the software and labeled with IUB codes: Y = T + C, R = A + G, W = A + T, H = C + T. The RECall software aligns all sequences to a reference at the top of each panel and shows the composite base call below the reference. The highlighted T position across all the panels is a vertical alignment position between the panels. Panel A shows 2 codons (37 and 41 of RT) with nucleotide base-calling of AYR; panel B shows the AWR at codon 41 (the second peaks at codon 37 were not detected in this replicate); panel C shows ACR at codon 37 (minor T was not called by RECall at the cutoff of 15%) and AHR at codon 41 (almost equal height of second and third peak at the second position) ( ).

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819071.ch53
1. Wu R, Kaiser AD. 1968. Structure and base sequence in the cohesive ends of bacteriophage lambda DNA. J Mol Biol 35:523537[CrossRef].[PubMed]
2. Sanger F, Nicklen S, Coulson AR. 1977. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:54635467[CrossRef].[PubMed]
3. Messing J, Crea R, Seeburg PH. 1981. A system for shotgun DNA sequencing. Nucleic Acids Res 9:309321[CrossRef].[PubMed]
4. Smith LM, Sanders JZ, Kaiser RJ, Hughes P, Dodd C, Connell CR, Heiner C, Kent SBH, Hood LE. 1986. Fluorescence detection in automated DNA sequence analysis. Nature 321:674679[CrossRef].[PubMed]
5. Ronaghi M, Karamohamed S, Pettersson B, Uhlén M, Nyrén P. 1996. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242:8489[CrossRef].[PubMed]
6. Venter JC, , et al. 2001. The sequence of the human genome. Science 291:13041351[CrossRef].[PubMed]
7. Margulies M, , et al. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376380.[PubMed]
8. Eid J, , et al. 2009. Real-time DNA sequencing from single polymerase molecules. Science 323:133138[CrossRef].[PubMed]
9. Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, Leamon JH, Johnson K, Milgrew MJ, Edwards M, Hoon J, Simons JF, Marran D, Myers JW, Davidson JF, Branting A, Nobile JR, Puc BP, Light D, Clark TA, Huber M, Branciforte JT, Stoner IB, Cawley SE, Lyons M, Fu Y, Homer N, Sedova M, Miao X, Reed B, Sabina J, Feierstein E, Schorn M, Alanjary M, Dimalanta E, Dressman D, Kasinskas R, Sokolsky T, Fidanza JA, Namsaraev E, McKernan KJ, Williams A, Roth GT, Bustillo J. 2011. An integrated semiconductor device enabling non-optical genome sequencing. Nature 475:348352[CrossRef].[PubMed]
10. Domingo E, Sheldon J, Perales C. 2012. Viral quasispecies evolution. Microbiol Mol Biol Rev 76:159216[CrossRef].[PubMed]
11. Palomino JC. 2009. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol 56:103111[CrossRef].[PubMed]
12. Rickerts V, Khot PD, Myerson D, Ko DL, Lambrecht E, Fredricks DN. 2011. Comparison of quantitative real time PCR with Sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens. BMC Infect Dis 11:202214[CrossRef].[PubMed]
13. Lau A, Chen S, Sorrell T, Carter D, Malik R, Martin P, Halliday C. 2007. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol 45:380385[CrossRef].[PubMed]
14. Moncada PA, Budvytiene I, Ho DY, Deresinski SC, Montoya JG, Banaei N. 2013. Utility of DNA sequencing for direct identification of invasive fungi from fresh and formalin-fixed specimens. Am J Clin Pathol 140:203208[CrossRef].[PubMed]
15. Conway C, Chalkley R, High A, Maclennan K, Berri S, Chengot P, Alsop M, Egan P, Morgan J, Taylor GR, Chester J, Sen M, Rabbitts P, Wood HM. 2012. Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors. J Mol Diagn 14:104111[CrossRef].[PubMed]
16. Däumer M, Kaiser R, Klein R, Lengauer T, Thiele B, Thielen A. 2011. Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis. BMC Med Inform Decis Mak 11:30[CrossRef]37.[PubMed]
17. Didelot X, Bowden R, Wilson DJ, Peto TE, Crook DW. 2012. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 13:601612[CrossRef].[PubMed]
18. Hasman H, Saputra D, Sicheritz-Ponten T, Lund O, Svendsen CA, Frimodt-Møller N, Aarestrup FM. 2014. Rapid whole-genome sequencing for detection and characterization of microorganisms directly from clinical samples. J Clin Microbiol 52:139146[CrossRef].[PubMed]
19. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, Scheutz F, Paxinos EE, Sebra R, Chin C-S, Iliopoulos D, Klammer A, Peluso P, Lee L, Kislyuk AO, Bullard J, Kasarskis A, Wang S, Eid J, Rank D, Redman JC, Steyert SR, Frimodt-Møller J, Struve C, Petersen AM, Krogfelt KA, Nataro JP, Schadt EE, Waldor MK. 2011. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 365:709717[CrossRef].[PubMed]
20. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Henkhaus JK, Leopold B, Bielaszewska M, Prager R, Brzoska PM, Moore RL, Guenther S, Rothberg JM, Karch H. 2011. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 6:e22751[CrossRef].[PubMed]
21. Brzuszkiewicz E, Thürmer A, Schuldes J, Leimbach A, Liesegang H, Meyer FD, Boelter J, Petersen H, Gottschalk G, Daniel R. 2011. Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC). Arch Microbiol 193:883891[CrossRef].[PubMed]
22. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN, Segre JA, Segre JA, NISC Comparative Sequencing Program Group.2012. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4:148ra116.
23. den Bakker HC, Allard MW, Bopp D, Brown EW, Fontana J, Iqbal Z, Kinney A, Limberger R, Musser KA, Shudt M, Strain E, Wiedmann M, Wolfgang WJ. 2014. Rapid whole-genome sequencing for surveillance of Salmonella enterica serovar enteritidis. Emerg Infect Dis 20:13061314[CrossRef].[PubMed]
24. Köser CU, Ellington MJ, Cartwright EJ, Gillespie SH, Brown NM, Farrington M, Holden MT, Dougan G, Bentley SD, Parkhill J, Peacock SJ. 2012. Routine use of microbial whole genome sequencing in diagnostic and public health microbiology. PLoS Pathog 8:e1002824[CrossRef].[PubMed]
25. Vence T. 2011. On Top of Outbreaks. Genomeweb. https://www.genomeweb.com/sequencing/top-outbreaks.
26. Wilson MR, Naccache SN, Samayoa E, Biagtan M, Bashir H, Yu G, Salamat SM, Somasekar S, Federman S, Miller S, Sokolic R, Garabedian E, Candotti F, Buckley RH, Reed KD, Meyer TL, Seroogy CM, Galloway R, Henderson SL, Gern JE, DeRisi JL, Chiu CY. 2014. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. N Engl J Med 370:24082417[CrossRef].[PubMed]
27. Ma Y, Madupu R, Karaoz U, Nossa CW, Yang L, Yooseph S, Yachimski PS, Brodie EL, Nelson KE, Pei Z. 2014. Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets. J Virol 88:47864797[CrossRef].[PubMed]
28. Qin J, , et al, MetaHIT Consortium. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:5965[CrossRef].[PubMed]
29. Nelson KE, , et al, Human Microbiome Jumpstart Reference Strains Consortium. 2010. A catalog of reference genomes from the human microbiome. Science 328:994999[CrossRef].[PubMed]
30. Methé BA, , et al, Human Microbiome Project Consortium. 2012. A framework for human microbiome research. Nature 486:215221[CrossRef].[PubMed]
31. Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, Hernandez RD, Lederman MM, Huang Y, Somsouk M, Deeks SG, Hunt PW, Lynch SV, McCune JM. 2013. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 5:193ra91.
32. Abdelrahman T, Hughes J, Main J, McLauchlan J, Thursz M, Thomson E. 2015. Next-generation sequencing sheds light on the natural history of hepatitis C infection in patients who fail treatment. Hepatology 61:8897[CrossRef].[PubMed]
33. Fonseca-Coronado S, Escobar-Gutiérrez A, Ruiz-Tovar K, Cruz-Rivera MY, Rivera-Osorio P, Vazquez-Pichardo M, Carpio-Pedroza JC, Ruíz-Pacheco JA, Cazares F, Vaughan G. 2012. Specific detection of naturally occurring hepatitis C virus mutants with resistance to telaprevir and boceprevir (protease inhibitors) among treatment-naïve infected individuals. J Clin Microbiol 50:281287[CrossRef].[PubMed]
34. Schuurman T, de Boer RF, Kooistra-Smid AMD, van Zwet AA. 2004. Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting. J Clin Microbiol 42:734740[CrossRef].[PubMed]
35. Muñoz-Cadavid C, Rudd S, Zaki SR, Patel M, Moser SA, Brandt ME, Gómez BL. 2010. Improving molecular detection of fungal DNA in formalin-fixed paraffin-embedded tissues: comparison of five tissue DNA extraction methods using panfungal PCR. J Clin Microbiol 48:21472153[CrossRef].[PubMed]
36. Shatzkes K, Teferedegne B, Murata H. 2014. A simple, inexpensive method for preparing cell lysates suitable for downstream reverse transcription quantitative PCR. Sci Rep 4:46594665[CrossRef].[PubMed]
37. Lee SH, Vigliotti VS, Pappu S. 2008. DNA sequencing validation of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid tests. Am J Clin Pathol 129:852859[CrossRef].[PubMed]
38. Lee SH, Vigliotti VS, Vigliotti JS, Pappu S. 2009. Validation of human papillomavirus genotyping by signature DNA sequence analysis. BMC Clin Pathol 9:313[CrossRef].[PubMed]
39. Ewing B, Green P. 1998. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8:186194[CrossRef].[PubMed]
40. Ewing B, Hillier L, Wendl MC, Green P. 1998. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8:175185[CrossRef].[PubMed]
41. Li L, Deng X, Mee ET, Collot-Teixeira S, Anderson R, Schepelmann S, Minor PD, Delwart E. 2015. Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent. J Virol Methods 213:139146[CrossRef].[PubMed]
42. Basehore MJ, Mcgee S, Kubiak K, King K, Butler J, Lee Ja, Jones JR, Friez MJ. 2013. The development and validation of a next generation sequencing panel for skeletal dysplasias, poster G52. Ann. Meet. Assoc. for Mol. Pathol. http://www.softgenetics.com/PDF/AMP2013_MJ-Basehore.pdf
43. Gibson RM, Meyer AM, Winner D, Archer J, Feyertag F, Ruiz-Mateos E, Leal M, Robertson DL, Schmotzer CL, Quiñones-Mateu ME. 2014. Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism. Antimicrob Agents Chemother 58:21672185[CrossRef].[PubMed]
44. Knierim E, Lucke B, Schwarz JM, Schuelke M, Seelow D. 2011. Systematic comparison of three methods for fragmentation of long-range PCR products for next generation sequencing. PLoS One 6:e28240[CrossRef].[PubMed]
45. Adey A, Morrison HG, Asan Xun X, Kitzman JO, Turner EH, Stackhouse B, MacKenzie AP, Caruccio NC, Zhang X, Shendure J. 2010. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol 11:R119.
46. Lamble S, Batty E, Attar M, Buck D, Bowden R, Lunter G, Crook D, El-Fahmawi B, Piazza P. 2013. Improved workflows for high throughput library preparation using the transposome-based Nextera system. BMC Biotechnol 13:104113[CrossRef].[PubMed]
47. Gao G, Johnson SH, Kasperbauer JL, Eckloff BW, Tombers NM, Vasmatzis G, Smith DI. 2014. Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer. J Clin Virol 59:195200[CrossRef].[PubMed]
48. Head SR, Komori HK, LaMere SA, Whisenant T, Van Nieuwerburgh F, Salomon DR, Ordoukhanian P. 2014. Library construction for next-generation sequencing: overviews and challenges. Biotechniques 56:6164, 66, 68 passim.[PubMed]
49. O'Brien HE, Gong Y, Fung P, Wang PW, Guttman DS. 2011. Use of low-coverage, large-insert, short-read data for rapid and accurate generation of enhanced-quality draft Pseudomonas genome sequences. PLoS One 6:e27199[CrossRef].[PubMed]
50. Shitikov EA, Bespyatykh JA, Ischenko DS, Alexeev DG, Karpova IY, Kostryukova ES, Isaeva YD, Nosova EY, Mokrousov IV, Vyazovaya AA, Narvskaya OV, Vishnevsky BI, Otten TF, Zhuravlev VI, Yablonsky PK, Ilina EN, Govorun VM. 2014. Unusual large-scale chromosomal rearrangements in Mycobacterium tuberculosis Beijing B0/W148 cluster isolates. PLoS One 9:e84971[CrossRef].[PubMed]
51. Lan JH, Yin Y, Reed EF, Moua K, Thomas K, Zhang Q. 2015. Impact of three Illumina library construction methods on GC bias and HLA genotype calling. Hum Immunol 76:166175[CrossRef].[PubMed]
52. Feehery GR, Yigit E, Oyola SO, Langhorst BW, Schmidt VT, Stewart FJ, Dimalanta ET, Amaral-Zettler LA, Davis T, Quail MA, Pradhan S. 2013. A method for selectively enriching microbial DNA from contaminating vertebrate host DNA. PLoS One 8:e76096[CrossRef].[PubMed]
53. Cooper RM, Leslie DC, Domansky K, Jain A, Yung C, Cho M, Workman S, Super M, Ingber DE. 2014. A microdevice for rapid optical detection of magnetically captured rare blood pathogens. Lab Chip 14:182188[CrossRef].[PubMed]
54. Huggett JF, Laver T, Tamisak S, Nixon G, O'Sullivan DM, Elaswarapu R, Studholme DJ, Foy CA. 2013. Considerations for the development and application of control materials to improve metagenomic microbial community profiling. Accredit Qual Assur 18:7783[CrossRef].
55. Fricke WF, Rasko DA. 2014. Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions. Nat Rev Genet 15:4955[CrossRef].[PubMed]
56. Abbas MM, Malluhi QM, Balakrishnan P. 2014. Assessment of de novo assemblers for draft genomes: a case study with fungal genomes. BMC Genomics 15(Suppl 9):S10S21[CrossRef].[PubMed]
57. Sabirova JS, Xavier BB, Ieven M, Goossens H, Malhotra-Kumar S. 2014. Whole genome mapping as a fast-track tool to assess genomic stability of sequenced Staphylococcus aureus strains. BMC Res Notes 7:704709[CrossRef].[PubMed]
58. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18:821829[CrossRef].[PubMed]
59. Caraballo Cortés K, Zagordi O, Laskus T, Pøoski R, Bukowska-Ośko I, Paweøczyk A, Berak H, Radkowski M. 2013. Ultradeep pyrosequencing of hepatitis C virus hypervariable region 1 in quasispecies analysis. BioMed Res Int 2013:111[CrossRef].[PubMed]
60. Naccache SN, Federman S, Veeraraghavan N, Zaharia M, Lee D, Samayoa E, Bouquet J, Greninger AL, Luk KC, Enge B, Wadford DA, Messenger SL, Genrich GL, Pellegrino K, Grard G, Leroy E, Schneider BS, Fair JN, Martínez MA, Isa P, Crump JA, DeRisi JL, Sittler T, Hackett J Jr, Miller S, Chiu CY. 2014. A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples. Genome Res 24:11801192[CrossRef].[PubMed]
61. Jennings L, Van Deerlin VM, Gulley ML, College of American Pathologists Molecular Pathology Resource Committee. 2009. Recommended principles and practices for validating clinical molecular pathology tests. Arch Pathol Lab Med 133:743755.[PubMed]
62. Schoenmakers CH, Naus AJ, Vermeer HJ, van Loon D, Steen G. 2011. Practical application of Sigma Metrics QC procedures in clinical chemistry. Clin Chem Lab Med 49:18371843[CrossRef].[PubMed]
63. WHO. 2016. WHO International Biological Reference Preparations: Held and Distributed by the WHO International Laboratories for Biological Standards. http://www.who.int/bloodproducts/catalogue/en/.
64. Underwood A, Green J. 2011. Call for a quality standard for sequence-based assays in clinical microbiology: necessity for quality assessment of sequences used in microbial identification and typing. J Clin Microbiol 49:2326[CrossRef].[PubMed]
65. Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, Lu F, Lyon E, Voelkerding KV, Zehnbauer BA, Agarwala R, Bennett SF, Chen B, Chin EL, Compton JG, Das S, Farkas DH, Ferber MJ, Funke BH, Furtado MR, Ganova-Raeva LM, Geigenmüller U, Gunselman SJ, Hegde MR, Johnson PL, Kasarskis A, Kulkarni S, Lenk T, Liu CS, Manion M, Manolio TA, Mardis ER, Merker JD, Rajeevan MS, Reese MG, Rehm HL, Simen BB, Yeakley JM, Zook JM, Lubin IM. 2012. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 30:10331036[CrossRef].[PubMed]
66. Lyon E, Cockerill FR III, Bale SJ, Beadling C, Bry L, Hagenkord J, Kulkarni S, Press R, Palomaki GE. 2015. Next generation sequencing in clinical diagnostics: experiences of early adopters. Clin Chem 61:4149[CrossRef].[PubMed]
67. Pont-Kingdon G, Gedge F, Wooderchak-Donahue W, Schrijver I, Weck KE, Kant JA, Oglesbee D, Bayrak-Toydemir P, Lyon E, Biochemical and Molecular Genetic Resource Committee of the College of American Pathologists. 2012. Design and analytical validation of clinical DNA sequencing assays. Arch Pathol Lab Med 136:4146[CrossRef].[PubMed]
68. Woo PC, Teng JL, Wu JK, Leung FP, Tse H, Fung AM, Lau SK, Yuen KY. 2009. Guidelines for interpretation of 16S rRNA gene sequence-based results for identification of medically important aerobic Gram-positive bacteria. J Med Microbiol 58:10301036[CrossRef].[PubMed]
69. Bosshard PP, Zbinden R, Abels S, Böddinghaus B, Altwegg M, Böttger EC. 2006. 16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol 44:13591366[CrossRef].[PubMed]
70. Mignard S, Flandrois JP. 2006. 16S rRNA sequencing in routine bacterial identification: a 30-month experiment. J Microbiol Methods 67:574581[CrossRef].[PubMed]
71. U.S. Department of Health and Human Services. 2014. Public Workshop—Advancing Regulatory Science for High Throughput Sequencing Devices for Microbial Identification and Detection of Antimicrobial Resistance Markers. http://www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm386967.htm.
72. Guembe M, Marín M, Martín-Rabadán P, Echenagusia A, Camúñez F, Rodríguez-Rosales G, Simó G, Echenagusia M, Bouza E, GEIDI Study Group. 2013. Use of universal 16S rRNA gene PCR as a diagnostic tool for venous access port-related bloodstream infections. J Clin Microbiol 51:799804[CrossRef].[PubMed]
73. Germer JJ, Abraham P, Mandrekar JN, Yao JDC. 2013. Evaluation of the Abbott HBV RUO sequencing assay combined with laboratory-modified interpretive software. J Clin Microbiol 51:95100[CrossRef].[PubMed]
74. Food and Drug Administration. 2007. Guidance for Industry and FDA Staff Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm071287.pdf.
75. Yi X, Zou J, Xu J, Liu T, Liu T, Hua S, Xi F, Nie X, Ye L, Luo Y, Xu L, Du H, Wu R, Yang L, Liu R, Yang B, Wang J, Belinson JL. 2014. Development and validation of a new HPV genotyping assay based on next-generation sequencing. Am J Clin Pathol 141:796804[CrossRef].[PubMed]
76. Altman DG,. 2000. Diagnostic tests, p 105119. In Altman DG,, Machin D,, Bryant TN,, Gardner MJ (ed), Statistics With Confidence, 2nd ed. BMJ Publishing Group, Bristol, United Kingdom.
77. Hess AS, Shardell M, Johnson JK, Thom KA, Strassle P, Netzer G, Harris AD. 2012. Methods and recommendations for evaluating and reporting a new diagnostic test. Eur J Clin Microbiol Infect Dis 31:21112116[CrossRef].[PubMed]
78. Russek-Cohen E, Feldblyum T, Whitaker KB, Hojvat S. 2011. FDA perspectives on diagnostic device clinical studies for respiratory infections. Clin Infect Dis 52(Suppl 4):S305S311[CrossRef].[PubMed]
79. State of New York Department of Health. 2011. Approval of Microbiology Nucleic Acid Amplification Assays. http://www.wadsworth.org/labcert/TestApproval/forms/Microbiology_NAAT_Checklist.pdf.
80. Ahmadi SH, Neela V, Hamat RA, Goh BL, Syafinaz AN. 2013. Rapid detection and identification of pathogens in patients with continuous ambulatory peritoneal dialysis (CAPD) associated peritonitis by 16s rRNA gene sequencing. Trop Biomed 30:602607.[PubMed]
81. Babouee B, Goldenberger D, Elzi L, Lardinois D, Sadowski-Cron C, Bubendorf L, Prince SS, Battegay M, Frei R, Weisser M. 2013. Prospective study of a panfungal PCR assay followed by sequencing, for the detection of fungal DNA in normally sterile specimens in a clinical setting: a complementary tool in the diagnosis of invasive fungal disease? Clin Microbiol Infect 19:E354E357[CrossRef].[PubMed]
82. Grif K, Heller I, Prodinger WM, Lechleitner K, Lass-Flörl C, Orth D. 2012. Improvement of detection of bacterial pathogens in normally sterile body sites with a focus on orthopedic samples by use of a commercial 16S rRNA broad-range PCR and sequence analysis. J Clin Microbiol 50:22502254[CrossRef].[PubMed]
83. Pérez-Osorio AC, Boyle DS, Ingham ZK, Ostash A, Gautom RK, Colombel C, Houze Y, Leader BT. 2012. Rapid identification of mycobacteria and drug-resistant Mycobacterium tuberculosis by use of a single multiplex PCR and DNA sequencing. J Clin Microbiol 50:326336[CrossRef].[PubMed]
84. Yokota M, Tatsumi N, Nathalang O, Yamada T, Tsuda I. 1999. Effects of heparin on polymerase chain reaction for blood white cells. J Clin Lab Anal 13:133140[CrossRef].[PubMed]
85. Khot PD, Fredricks DN. 2009. PCR-based diagnosis of human fungal infections. Expert Rev Anti Infect Ther 7:12011221[CrossRef].[PubMed]
86. Fenollar F, Roux V, Stein A, Drancourt M, Raoult D. 2006. Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections. J Clin Microbiol 44:10181028[CrossRef].[PubMed]
87. CLSI. 2012. Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline—Second Edition. CLSI document EP-17-A2. http://shop.clsi.org/method-evaluation-documents/EP17.html
88. Hayden RT, Gu Z, Ingersoll J, Abdul-Ali D, Shi L, Pounds S, Caliendo AM. 2013. Comparison of droplet digital PCR to real-time PCR for quantitative detection of cytomegalovirus. J Clin Microbiol 51:540546[CrossRef].[PubMed]
89. Huggett JF, Foy CA, Benes V, Emslie K, Garson JA, Haynes R, Hellemans J, Kubista M, Mueller RD, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT, Bustin SA. 2013. The digital MIQE guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments. Clin Chem 59:892902[CrossRef].[PubMed]
90. Choe S, Han D, Cheng M, Anton E, Stawiski E, Penuel E, Parkin N, Petropoulos CJ, Reeves JD. 2010. Validation of the GENESEQ™ HCV NS5B sequencing assay for patient-derived HCV subtypes 1A and 1B. J Hepatol 52:S298. http://www.journal-of-hepatology.eu/article/S0168-8278%2810%2960768-4/abstract.
91. Anton ED, Rivera AA, Tan Y, Choe S, Toma J, Newton A, Larson J, Whitcomb J, Huang W, Reeves JD. 2011. Validation of an HCV C NS3/4A Sequencing Assay for Evaluating Resistance to Boceprevir, Telaprevir and Protease Inhibitor Candidates in a Clinical Reference Laboratory Setting, poster LB-23. 62nd Ann Meet Am Soc Study Liver Dis. http://www.monogrambio.com/sites/default/files/Validation_of_an_HCV_NS34A_Sequencing_Assay.pdf.
92. Arosio M, Nozza F, Rizzi M, Ruggeri M, Casella P, Beretta G, Raglio A, Goglio A. 2008. Evaluation of the MicroSeq 500 16S rDNA-based gene sequencing for the diagnosis of culture-negative bacterial meningitis. New Microbiol 31:343349.[PubMed]
93. Fantin YS, Neverov AD, Favorov AV, Alvarez-Figueroa MV, Braslavskaya SI, Gordukova MA, Karandashova IV, Kuleshov KV, Myznikova AI, Polishchuk MS, Reshetov DA, Voiciehovskaya YA, Mironov AA, Chulanov VP. 2013. Base-calling algorithm with vocabulary (BCV) method for analyzing population sequencing chromatograms. PLoS One 8:e54835[CrossRef].[PubMed]
94. Kagan RM, Johnson EP, Siaw M, Biswas P, Chapman DS, Su Z, Platt JL, Pesano RL. 2012. A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients. PLoS One 7:e46334[CrossRef].[PubMed]
95. FDA. Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests—Preliminary Discussion Paper. http://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM427869.pdf.
96. Aires-de-Sousa M, Boye K, de Lencastre H, Deplano A, Enright MC, Etienne J, Friedrich A, Harmsen D, Holmes A, Huijsdens XW, Kearns AM, Mellmann A, Meugnier H, Rasheed JK, Spalburg E, Strommenger B, Struelens MJ, Tenover FC, Thomas J, Vogel U, Westh H, Xu J, Witte W. 2006. High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol 44:619621[CrossRef].[PubMed]
97. Zhou Z, Wagar N, DeVos JR, Rottinghaus E, Diallo K, Nguyen DB, Bassey O, Ugbena R, Wadonda-Kabondo N, McConnell MS, Zulu I, Chilima B, Nkengasong J, Yang C. 2011. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings. PLoS One 6:e28184[CrossRef].[PubMed]
98. Shafer RW, Hertogs K, Zolopa AR, Warford A, Bloor S, Betts BJ, Merigan TC, Harrigan R, Larder BA. 2001. High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. J Clin Microbiol 39:15221529[CrossRef].[PubMed]
99. Campo DS, Dimitrova Z, Yamasaki L, Skums P, Lau DT, Vaughan G, Forbi JC, Teo C-G, Khudyakov Y. 2014. Next-generation sequencing reveals large connected networks of intra-host HCV variants. BMC Genomics 15(Suppl 5):S4S12[CrossRef].[PubMed]
100. Strong MJ, Xu G, Morici L, Splinter Bon-Durant S, Baddoo M, Lin Z, Fewell C, Taylor CM, Flemington EK. 2014. Microbial contamination in next generation sequencing: implications for sequence-based analysis of clinical samples. PLoS Pathog 10:e1004437[CrossRef].[PubMed]
101. CLSI. 2010. Nucleic Acid Sequencing Methods in Diagnostic Laboratory Medicine; Approved Guideline, 2nd ed. CLSI document MM09-A2. http://shop.clsi.org/molecular-methods-documents/MM09.html
102. Remillard EM, Taylor LK, Layshock J, Van Cuyk S, Omberg KM. 2013. Detecting laboratory DNA contamination using polyester-rayon wipes: a method validation study. J Microbiol Methods 92:358365[CrossRef].[PubMed]
103. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, Turner P, Parkhill J, Loman NJ, Walker AW. 2014. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol 12:8798[CrossRef].[PubMed]
104. Naccache SN, Hackett J Jr, Delwart EL, Chiu CY. 2014. Concerns over the origin of NIH-CQV, a novel virus discovered in Chinese patients with seronegative hepatitis. Proc Natl Acad Sci USA 111:E976[CrossRef].[PubMed]
105. Naccache SN, Greninger AL, Lee D, Coffey LL, Phan T, Rein-Weston A, Aronsohn A, Hackett J Jr, Delwart EL, Chiu CY. 2013. The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns. J Virol 87:1196611977[CrossRef].[PubMed]
106. Smuts H, Kew M, Khan A, Korsman S. 2014. Novel hybrid parvovirus-like virus, NIH-CQV/PHV, contaminants in silica column-based nucleic acid extraction kits. J Virol 88:1398[CrossRef].[PubMed]
107. Salipante SJ, Sengupta DJ, Rosenthal C, Costa G, Spangler J, Sims EH, Jacobs MA, Miller SI, Hoogestraat DR, Cookson BT, McCoy C, Matsen FA, Shendure J, Lee CC, Harkins TT, Hoffman NG. 2013. Rapid 16S rRNA next-generation sequencing of polymicrobial clinical samples for diagnosis of complex bacterial infections. PLoS One 8:e65226[CrossRef].[PubMed]
108. Aslanzadeh J. 2004. Preventing PCR amplification carryover contamination in a clinical laboratory. Ann Clin Lab Sci 34:389396.[PubMed]
109. Longo MC, Berninger MS, Hartley JL. 1990. Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93:125128[CrossRef].[PubMed]
110. University of Maryland. 2014. Press Release: Institute for Genome Sciences Awarded FDA Contract to Expand Genome Sequence Database for Pathogen Identification. http://www.igs.umaryland.edu/labs/grc/files/2014/04/FDA-Announcement-3-26-14_final.pdf.
111. Hall L, Doerr KA, Wohlfiel SL, Roberts GD. 2003. Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory. J Clin Microbiol 41:14471453[CrossRef].[PubMed]
112. Kwong AD, Najera I, Bechtel J, Bowden S, Fitzgibbon J, Harrington P, Kempf D, Kieffer TL, Koletzki D, Kukolj G, Lim S, Pilot-Matias T, Lin K, Mani N, Mo H, O'Rear J, Otto M, Parkin N, Pawlotsky JM, Petropoulos C, Picchio G, Ralston R, Reeves JD, Schooley RT, Seiwert S, Standring D, Stuyver L, Sullivan J, Miller V, Forum for Collaborative Human Immunodeficiency Virus Research, HCV Drug Development Advisory Group. (HCV DRAG), Sequence Analysis Working Group (SAWG), Phenotype Analysis Working Group (PAWG). 2011. Sequence and phenotypic analysis for resistance monitoring in hepatitis C virus drug development: recommendations from the HCV DRAG. Gastroenterology 140:755760.
113. Cloud JL, Neal H, Rosenberry R, Turenne CY, Jama M, Hillyard DR, Carroll KC. 2002. Identification of Mycobacterium spp. by using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. J Clin Microbiol 40:400406[CrossRef].[PubMed]
114. Drancourt M, Bollet C, Carlioz A, Martelin R, Gayral JP, Raoult D. 2000. 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. J Clin Microbiol 38:36233630.[PubMed]
115. Turenne CY, Tschetter L, Wolfe J, Kabani A. 2001. Necessity of quality-controlled 16S rRNA gene sequence databases: identifying nontuberculous Mycobacterium species. J Clin Microbiol 39:36373648[CrossRef].[PubMed]
116. Waterman M. 1995. Dynamic programming alignment of two sequences, p 201202. In Introduction to Computational Biology. Chapman & Hall, London, England.[CrossRef]
117. College of American Pathologists. 2014. CAP Microbiology Checklist. CAP, Northfield, IA.
118. Kommedal O, Lekang K, Langeland N, Wiker HG. 2011. Characterization of polybacterial clinical samples using a set of group-specific broad-range primers targeting the 16S rRNA gene followed by DNA sequencing and RipSeq analysis. J Med Microbiol 60:927936[CrossRef].[PubMed]
119. Tardif KD, Simmon KE, Kommedal O, Pyne MT, Schlaberg R. 2013. Sequencing-based genotyping of mixed human papillomavirus infections by use of RipSeq software. J Clin Microbiol 51:12781280[CrossRef].[PubMed]
120. Parker WT, Phillis SR, Yeung DT, Hughes TP, Scott HS, Branford S. 2014. Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination. Blood 124:153155[CrossRef].[PubMed]
121. Kühn C, Disqué C, Mühl H, Orszag P, Stiesch M, Haverich A. 2011. Evaluation of commercial universal rRNA gene PCR plus sequencing tests for identification of bacteria and fungi associated with infectious endocarditis. J Clin Microbiol 49:29192923[CrossRef].[PubMed]
122. Life Technologies. 2011. Independent QC materials for hospital-acquired infection (HAI) testing: AcroMetrix® quality controls. http://www.lifetechnologies.com/content/dam/LifeTech/migration/files/clinical-research-and-diagnostic-applications/pdfs.par.95522.file.dat/acrometrix hai product bullletin.pdf.
123. Olson N, Zook J, Vang L, Catoe D, McDaniel J, Salit M. 2014. Microbial Genomic Reference Materials. http://www.fda.gov/downloads/MedicalDevices/NewsEvents/WorkshopsConferences/UCM393056.pdf.
124. Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E, Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Commitee. 2013. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15:733747[CrossRef].[PubMed]
125. Shafer RW, Dupnik K, Winters MA, Eshleman SH. 2001. A guide to HIV-1 reverse transcriptase and protease sequencing for drug resistance studies. HIV Seq Compend 2001:151.[PubMed]
126. Torres-Puente M, Bracho MA, Jiménez N, García-Robles I, Moya A, González-Candelas F. 2003. Sampling and repeatability in the evaluation of hepatitis C virus genetic variability. J Gen Virol 84:23432350[CrossRef].[PubMed]
127. Zhou B, Lin X, Wang W, Halpin RA, Bera J, Stockwell TB, Barr IG, Wentworth DE. 2014. Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics. J Clin Microbiol 52:13301337[CrossRef].[PubMed]

Tables

Generic image for table
TABLE 1

Examples of sequencing technology applications

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53
Generic image for table
TABLE 2

Selected resources for sequencing assay development

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53
Generic image for table
TABLE 3

Examples of analytical validation strategies

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53
Generic image for table
TABLE 4

Example nucleic acid input amounts across various platforms

Citation: Norman K, Dinauer D. 2016. Practices of Sequencing Quality Assurance, p 766-783. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555819071.ch53

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error